These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3544736)

  • 21. [Bases for antibacterial treatment].
    Katranushkova N
    Akush Ginekol (Sofiia); 1979; 18(6):437-44. PubMed ID: 525722
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibacterial agents, bacterial resistance, and susceptibility tests.
    Dziarski R; Axler DA
    J Am Podiatr Med Assoc; 1985 Feb; 75(2):66-82. PubMed ID: 3884771
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical relevance of low concentrations of antibiotics.
    Lorian V
    J Antimicrob Chemother; 1993 May; 31 Suppl D():137-48. PubMed ID: 8335515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagomimetic action of antibiotics: Revisited. How do antibiotics know where to go?
    Gutteridge JMC; Quinlan GJ; Kovacic P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):721-724. PubMed ID: 31703841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Critical clinical study of the antibacterial activity of the serum of patients treated with antibiotics].
    Armengaud M; Auvergnat JC; Massip P; Mars A; Lemozy J; Lareng MB; Dabernat H
    Rev Med Interne; 1980; 1(1):113-20. PubMed ID: 7232903
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinspired surfaces against bacterial infections.
    Gomes J; Grunau A; Lawrence AK; Eberl L; Gademann K
    Chimia (Aarau); 2013; 67(4):275-8. PubMed ID: 23967705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resilient bacteria making our antibiotics ineffective.
    Can Oper Room Nurs J; 1987 Feb; 5(1):6-9. PubMed ID: 3644692
    [No Abstract]   [Full Text] [Related]  

  • 29. Low concentrations of antibiotics.
    Lorian V
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():15-26. PubMed ID: 3980327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-adhesion methods as novel therapeutics for bacterial infections.
    Cozens D; Read RC
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1457-68. PubMed ID: 23253323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of antibacterial resistance.
    Hickey SM; Nelson JD
    Adv Pediatr; 1997; 44():1-41. PubMed ID: 9265966
    [No Abstract]   [Full Text] [Related]  

  • 32. Hope for the post-antibiotic era?
    Irvin RT; Bautista DL
    Nat Biotechnol; 1999 Jan; 17(1):20. PubMed ID: 9920259
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotics and the host-parasite relationship (a short review).
    Gemmell CG
    Acta Microbiol Immunol Hung; 1996; 43(2-3):107-14. PubMed ID: 8876726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tetracycline].
    Totsuka K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():835-7. PubMed ID: 12718071
    [No Abstract]   [Full Text] [Related]  

  • 35. Microbial resistance to antibiotics. An evolving and persistent problem.
    Levy SB
    Lancet; 1982 Jul; 2(8289):83-8. PubMed ID: 6123819
    [No Abstract]   [Full Text] [Related]  

  • 36. Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship.
    Miller TE
    Eur J Clin Microbiol; 1984 Aug; 3(4):285-7. PubMed ID: 6489320
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacterial resistance to antibiotics.
    Ebrahim GJ
    J Trop Pediatr; 1995 Jun; 41(3):130-1. PubMed ID: 7636929
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiologic aspects of microorganism resistance to antibiotics].
    Výmola F
    Vnitr Lek; 1979 Dec; 25(12):1161-4. PubMed ID: 524758
    [No Abstract]   [Full Text] [Related]  

  • 39. [What is the role of clinical pharmacology in the present-day selection of antibacterial antibiotics?].
    Chruściel TL
    Przegl Lek; 1984; 41(4):347-50. PubMed ID: 6379756
    [No Abstract]   [Full Text] [Related]  

  • 40. Design, synthesis, and evaluation of novel oxazolidinone antibacterial agents active against multidrug-resistant bacteria.
    Barbachyn MR; Brickner SJ; Gadwood RC; Garmon SA; Grega KC; Hutchinson DK; Munesada K; Reischer RJ; Taniguchi M; Thomasco LM; Toops DS; Yamada H; Ford CW; Zurenko GE
    Adv Exp Med Biol; 1998; 456():219-38. PubMed ID: 10549371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.